Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors

Over the last decade, immune checkpoint inhibitors (ICIs) have revolutionized the treatment of several cancer types. ICIs work through the blockage of immune inhibitory signals, while increasing the T-cell specific immune antitumoral response. However, due to the fact that ICIs’ mechanism of action...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilariño, Noelia, Bruna, Jordi, Kalofonou, Foteini, Anastopoulou, Garifallia G., Argyriou, Andreas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461114/
https://www.ncbi.nlm.nih.gov/pubmed/32796758
http://dx.doi.org/10.3390/ijms21165774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461114/
https://www.ncbi.nlm.nih.gov/pubmed/32796758
http://dx.doi.org/10.3390/ijms21165774

Ejemplares similares